Original air date: 12/18/19
This course has expired and is no longer eligible for CLE.
Every patent attorney is well aware of the Doctrines of Equivalents and
Estoppel. But the application of these two doctrines is very
unpredictable in biotechnology. Recent case law has brought some more
examples to follow but there is much to learn on prosecution and
litigation strategies to maneuver and take advantage of these doctrines.
Our
speakers will present very insightful views on the subject. Kevin
Noonan, a celebrated blogger with Patent Docs will bring his extensive
and critical blogger views and Amanda Murphy, a partner at Finnegan,
will focus on prosecution strategies. Both speakers are bound to share
significant experience and answer questions in a very insightful way.
Speakers: Kevin Noonan & Amanda Murphy
Coordinator: Carla Mouta-Bellum